Patients experiencing chest pain often undergo imaging as CT Angiography and stress echocardiography tests that do not change treatment decisions, even when clinical examination with a simple Electro Cardiogram determines low risk of a cardiac event, according to a secondary finding from a retrospective analysis of the Rule Out Myocardial Ischemia/Infarction by Computer Assisted Tomography (ROMICAT-II) trial, presented at the 2017 Annual Scientific Sessions of the American Heart Association (AHA). The only effects of noninvasive additional testing are prolonging a padotient’s stay at the hospital and exposing patients to more ionising radiation, commented presenter from Washington University.
In the ROMICAT-II trial, investigators randomised 1,000 patients with acute chest pain into 2 groups that would receive either coronary computed tomography (CT) or stress testing to rule out a…